logo

Eiger Biopharmaceuticals Inc. (EIGR)



Trade EIGR now with
  Date
  Headline
6/18/2019 10:22:33 AM Wedbush Reiterates Eiger BioPharmaceuticals Inc. (EIGR) At Outperform With $35 Price Target
3/28/2019 7:21:51 AM Wedbush Reiterates Eiger BioPharmaceuticals Inc. (EIGR) At Outperform With $43 Price Target
8/13/2018 7:27:30 AM Wedbush Is Increasing Eiger BioPharmaceuticals Inc. (EIGR) FY19 Estimate To -2.60 From -2.78
8/13/2018 7:27:13 AM Wedbush Is Increasing Eiger BioPharmaceuticals Inc. (EIGR) Q4 19 Estimate To -0.69 From -0.73
8/13/2018 7:26:51 AM Wedbush Is Raising Eiger BioPharmaceuticals Inc. (EIGR) Q3 19 Estimate To -0.66 From -0.71
8/13/2018 7:26:33 AM Wedbush Is Increasing Eiger BioPharmaceuticals Inc. (EIGR) Q2 19 Estimate To -0.64 From -0.68
8/13/2018 7:26:22 AM Wedbush Is Raising Eiger BioPharmaceuticals Inc. (EIGR) Q1 19 Estimate To -0.61 From -0.66
8/13/2018 7:26:09 AM Wedbush Is Cutting Eiger BioPharmaceuticals Inc. (EIGR) FY18 Estimate To -2.71 From -2.65
8/13/2018 7:25:46 AM Wedbush Reiterates Eiger BioPharmaceuticals Inc. (EIGR) At Outperform With $53 Price Target
5/17/2018 7:21:11 AM Wedbush Is Cutting Eiger BioPharmaceuticals Inc. (EIGR) FY19 Estimate To -2.78 From -2.42
5/17/2018 7:20:59 AM Wedbush Is Cutting Eiger BioPharmaceuticals Inc. (EIGR) Q4 19 Estimate To -0.73 From -0.64
5/17/2018 7:20:46 AM Wedbush Is Cutting Eiger BioPharmaceuticals Inc. (EIGR) Q3 19 Estimate To -0.71 From -0.62
5/17/2018 7:20:33 AM Wedbush Is Cutting Eiger BioPharmaceuticals Inc. (EIGR) Q2 19 Estimate To -0.68 From -0.59
5/17/2018 7:20:18 AM Wedbush Is Lowering Eiger BioPharmaceuticals Inc. (EIGR) Q1 19 Estimate To -0.66 From -0.57
5/17/2018 7:20:04 AM Wedbush Is Lowering Eiger BioPharmaceuticals Inc. (EIGR) FY18 Estimate To -2.65 From -2.32
5/17/2018 7:19:49 AM Wedbush Is Cutting Eiger BioPharmaceuticals Inc. (EIGR) Q4 18 Estimate To -0.53 From -0.46
5/17/2018 7:19:37 AM Wedbush Is Cutting Eiger BioPharmaceuticals Inc. (EIGR) Q3 18 Estimate To -0.60 From -0.53
5/17/2018 7:19:23 AM Wedbush Is Lowering Eiger BioPharmaceuticals Inc. (EIGR) Q2 18 Estimate To -0.70 From -0.61
5/17/2018 7:18:44 AM Wedbush Reiterates Eiger BioPharmaceuticals Inc. (EIGR) At Outperform With $53 Up From $36 Price Target
5/9/2018 1:35:56 PM B. Riley FBR Starts Eiger BioPharmaceuticals Inc. (EIGR) At Buy With $24 Price Target